EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR

Marissa Borgese, David Badesch, Todd Bull, Murali Chakinala, Teresa DeMarco, Jeremy Feldman, H. James Ford, Dan Grinnan, James R. Klinger, Lena Bolivar, Oksana A. Shlobin, Robert P. Frantz, Jeffery S. Sager, Stephen C. Mathai, Steven Kawut, Peter J. Leary, Michael P. Gray, Rita A. Popat, Roham T. Zamanian

Source: Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marissa Borgese, David Badesch, Todd Bull, Murali Chakinala, Teresa DeMarco, Jeremy Feldman, H. James Ford, Dan Grinnan, James R. Klinger, Lena Bolivar, Oksana A. Shlobin, Robert P. Frantz, Jeffery S. Sager, Stephen C. Mathai, Steven Kawut, Peter J. Leary, Michael P. Gray, Rita A. Popat, Roham T. Zamanian. EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR. Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
Source: Eur Respir J 2014; 43: 1106-1113
Year: 2014



Health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011

Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005

Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011



Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015



Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020
Year: 2021



Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006



EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life
Source: Eur Respir J, 59 (1) 2100917; 10.1183/13993003.00917-2021
Year: 2022



The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018




Relationship between health-related quality of life and pulmonary function in COPD outpatients
Source: Eur Respir J 2002; 20: Suppl. 38, 253s
Year: 2002

Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Links between psychological factors and health-related quality of life in pulmonary hypertension
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016